Skip To Main Content
Barbara Ressler on Muck Rack

Barbara Ressler

As seen in: Cell & Gene Therapy Insights
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

iPSC cell line development and manufacture for cell therapies

|
By Rowan Flynn, Barbara Ressler, Derek Hei, Mark Tomishima
| Cell & Gene Therapy Insights Verified
Thursday 08:00 PDT / 11:00 EDT / 15:00 GMT / 16:00 CET Induced pluripotent stem cells (iPSCs) are poised to play a pivotal role in cell therapy, providing a versatile starting material for generating therapeutic cells and offering the potential for personalized medicine. Their relevance is highlighted by the growing need for timely provision of effective, off-the-shelf cell therapy solutions at a reasonable price point.
Open in Who Shared Issue with article?
See all 1 articles